You may also like
Compassionate Use of Remdesivir for Patients with Severe Covid-19
We provided remdesivir on a compassionate-use basis to patients hospitalized with Covid-19, the illness caused by infection with SARS-CoV-2.
1 min read
New Developments in the Use of Biologics and Other Modalities in the Management of Lateral Epicondylitis
This review discusses the current evidence for the use of platelet rich plasma (PRP), autologous whole blood injections (ABIs), and stem cell therapies for treatment of lateral epicondylitis. We also review the evidence for non biologic treatments including corticosteroids, prolotherapy, botulinum toxin A, and nitric oxide.
1 min read
Perfusion.com Cardiovascular News Roundup: <br>September 15, 2022</br>
Weekly roundup of interesting reads for the perfusion community, this week including new reviews, COVID trials, transplant news, and interesting findings on blood groups.
2 min read